Abstract
Background
Among patients diagnosed with schizophrenia, the presence of substance use poses an aggravating comorbidity, exerting a negative impact on the course of the disease, adherence to therapeutic regimens, treatment outcomes, duration of hospital stays, and the frequency of hospitalizations. The primary objective of the present study is to investigate the relationship between comorbid substance use disorders, antipsychotic treatment, and the length of stay in individuals hospitalized for treatment of schizophrenia.Methods
We conducted a retrospective analysis of electronic health records spanning a 12-month period, specifically focusing on adult patients diagnosed with schizophrenia who were discharged from the University Hospital of Psychiatry Zurich between January and December 2019. We documented the number and types of diagnosed substance use disorder, the antipsychotic treatment, the length of stay, and the number of previous hospitalizations for each patient.Results
Over a third (n = 328; 37.1%) of patients with schizophrenia had comorbid substance use with cannabis being the most frequent consumed substance. Patients with substance use (either single or multiple) were more frequently hospitalized; those with multiple substance use more frequently than those with a single substance use (F(2, 882) = 69.06; p < 0.001). There were no differences regarding the rate of compulsory admission. Patients with no substance use had a lower HoNOS score at discharge (F(2, 882) = 4.06). Patients with multiple substance use had a shorter length of stay (F(2, 882) = 9.22; p < 0.001), even after adjusting for duration of illness, previous hospitalizations, diagnosis, and antipsychotic treatment.Conclusions
In patients with schizophrenia, comorbid single or multiple substance use has a relevant negative impact on treatment and thus on the course of disease. Substance use in patients with schizophrenia should therefore receive special attention in order to reduce re-hospitalization rates and improve the clinical outcome.Full text links
Read article at publisher's site: https://doi.org/10.1186/s12916-024-03447-3
Read article for free, from open access legal sources, via Unpaywall: https://bmcmedicine.biomedcentral.com/counter/pdf/10.1186/s12916-024-03447-3
References
Articles referenced by this article (26)
The impact of substance use disorders on the course of schizophrenia--a 15-year follow-up study: dual diagnosis over 15 years.
Schizophr Res, (1-3):228-233 2011
MED: 21592731
The Effects of Cannabis on Inpatient Agitation, Aggression, and Length of Stay.
J Dual Diagn, (3-4):244-251 2016
MED: 27710762
Psychiatric Hospitalization and Length of Stay Differences in Cannabis Users and Non-Users with a Primary Discharge Diagnosis of Schizophrenia or Schizoaffective Disorder.
Subst Use Misuse, (11):1736-1739 2021
MED: 34263706
Prognosis of schizophrenia in persons with and without a history of cannabis use.
Psychol Med, (12):2513-2521 2014
MED: 25055170
Hospital Stay in Synthetic Cannabinoid Users With Bipolar Disorder, Schizophrenia, or Other Psychotic Disorders Compared With Cannabis Users.
J Stud Alcohol Drugs, (2):230-235 2019
MED: 31014468
Reasons for substance use among people with mental disorders.
Addict Behav, (4):427-434 2011
MED: 22197045
Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis.
Drug Alcohol Depend, 234-258 2018
MED: 30153606
The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
Soc Psychiatry Psychiatr Epidemiol, (12):939-946 2005
MED: 16247563
Routine health insurance data for scientific research: potential and limitations of the Agis Health Database.
J Clin Epidemiol, (4):424-430 2011
MED: 20800994
Comorbid substance use and age at onset of schizophrenia.
Br J Psychiatry, 237-242 2006
MED: 16507965
Show 10 more references (10 of 26)
Citations & impact
This article has not been cited yet.
Impact metrics
Alternative metrics
Discover the attention surrounding your research
https://www.altmetric.com/details/164430047
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963-2016.
J Dual Diagn, 15(3):130-139, 12 May 2019
Cited by: 6 articles | PMID: 31079564
Substance abuse and the management of medication nonadherence in schizophrenia.
J Nerv Ment Dis, 194(6):454-457, 01 Jun 2006
Cited by: 26 articles | PMID: 16772865
Impact of Paliperidone Palmitate Versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans With Schizophrenia and Comorbid Substance Abuse.
Clin Ther, 39(7):1380-1395.e4, 20 Jun 2017
Cited by: 13 articles | PMID: 28641996
Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
J Clin Psychiatry, 66 Suppl 6:21-26, 01 Jan 2005
Cited by: 41 articles | PMID: 16107180
Review